RETRACTED: Hassanin et al. Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFRL858R/T790M Mutations. Pharmaceuticals 2022, 15, 857
Pharmaceuticals · 11.11.2026 · 19 (11) · 1788
DOI: 10.3390/ph19111788 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 11.11.2026. Verfasst von Moamen A Hassanin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Umm Al-Qura University.
Abstract (Originalsprache)
The journal retracts the article titled “Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFRL858R/T790M Mutations” [...]
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
- Department of Medicinal Chemistry, Faculty of Pharmacy, Deraya University, Minia 61111, Egypt.
- Department of Pharmaceutics, Faculty of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia.
- Department of Medicinal Chemistry, Faculty of Pharmacy, Port Said University, Port Said 42511, Egypt.
ORCID-Profile: Moamen A Hassanin, Muhamad Mustafa, Mohammed A S Abourehab, Omar M Aly
Förderung
- Umm Al-Qura University
Zitieren
APA
Hassanin, M. A., Mustafa, M., Abourehab, M. A. S., Hassan, H. A., Aly, O. M., & Beshr, E. A. M. (2026). RETRACTED: Hassanin et al. Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFRL858R/T790M Mutations. Pharmaceuticals 2022, 15, 857. Pharmaceuticals, 19(11), 1788. https://doi.org/10.3390/ph19111788
Vancouver
Hassanin MA, Mustafa M, Abourehab MAS, Hassan HA, Aly OM, Beshr EAM. RETRACTED: Hassanin et al. Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFRL858R/T790M Mutations. Pharmaceuticals 2022, 15, 857. Pharmaceuticals. 2026;19(11):1788. doi:10.3390/ph19111788
BibTeX
@article{Hassanin2026,
author = {Hassanin, Moamen A and Mustafa, Muhamad and Abourehab, Mohammed A S and Hassan, Heba A and Aly, Omar M and Beshr, Eman A M},
title = {RETRACTED: Hassanin et al. Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFRL858R/T790M Mutations. Pharmaceuticals 2022, 15, 857},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {11},
pages = {1788},
doi = {10.3390/ph19111788}
}
EUVIMED